Citation Impact
Citing Papers
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Risk Factors for Stroke in Type 2 Diabetes Mellitus
1999
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement
2013
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
2000
Kidney stones: pathophysiology and medical management
2006 Standout
Diabetic retinopathy
2010 Standout
Sexual behaviour in context: a global perspective
2006 Standout
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
2003 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
2000 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Correlation of Thyroglobulin Concentrations Measured by Radioimmunoassay and Immunoradiometric Assay and the Influence of Thyroglobulin Antibody
2009
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas
2005
U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM
1995 StandoutNobel
Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus<SUBTITLE>Progressive Requirement for Multiple Therapies (UKPDS 49)</SUBTITLE>
1999 Standout
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)
2006
Graves' Ophthalmopathy
2010 Standout
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Type 1 diabetes
2013 Standout
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
2003
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47)
1999
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
1998
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)
2005
United Kingdom Prospective Diabetes Study, 30
1998
Current Thyroglobulin Autoantibody (TgAb) Assays Often Fail to Detect Interfering TgAb that Can Result in the Reporting of Falsely Low/Undetectable Serum Tg IMA Values for Patients with Differentiated Thyroid Cancer
2011
Global estimates of the prevalence of diabetes for 2010 and 2030
2009 Standout
Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
2000
Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus
2004
Sympathetic overactivity in active ulcerative colitis: effects of clonidine
2005
Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC)
2011
Influence of Calcium-Sensing Receptor Gene on Urinary Calcium Excretion in Stone-Forming Patients
2002
Comparison of a high‐carbohydrate and a high‐monounsaturated fat, olive oil‐rich diet on the susceptibility of LDL to oxidative modification in subjects with Type 2 diabetes mellitus
2004
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
UKPDS 60
2002
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Insight into Graves’ Hyperthyroidism from Animal Models
2005
Approach to maintaining comparability of biochemical data during long-term clinical trials.
1997
Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors
2006 Standout
Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus
2007
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
The Angiotensin-Converting Enzyme Gene and the Angiotensin II Type I Receptor Gene as Candidate Genes for Microalbuminuria
1997
Diabetic Cardiomyopathy
2018 Standout
Artificial Pancreas: Past, Present, Future
2011
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
2001
Sulfonylurea Inadequacy
2002
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
The Diabetes Prevention Program
2002
Hyperglycemic Crises in Adult Patients With Diabetes
2009 Standout
Insulin Pump Therapy
2003
Prevalence of diabetes mellitus in Croatia
2008
Are Lower Fasting Plasma Glucose Levels at Diagnosis of Type 2 Diabetes Associated With Improved Outcomes?
2002
Mechanisms of Diabetic Complications
2013 Standout
Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia
2011
The Metabolic Syndrome
2008 Standout
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Accuracy of an Electrochemical Sensor for Measuring Capillary Blood Ketones by Fingerstick Samples During Metabolic Deterioration After Continuous Subcutaneous Insulin Infusion Interruption in Type 1 Diabetic Patients
2003
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
2013 Standout
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
The Treat-to-Target Trial
2003 Standout
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Diabetic Retinopathy and Serum Lipoprotein Subclasses in the DCCT/EDIC Cohort
2004
Works of Laurent Meyer being referenced
UK PROSPECTIVE DIABETES STUDY (UKPDS) .11. BIOCHEMICAL RISK-FACTORS IN TYPE-2 DIABETIC-PATIENTS AT DIAGNOSIS COMPARED WITH AGE-MATCHED NORMAL SUBJECTS
1994
Increased sensitivity of a new assay for anti-thyroglobulin antibody detection in patients with autoimmune thyroid disease
2003
Health education pamphlets about smoking—their benefit to smokers and non-smokers
1999
A new missense mutation in the calcium‐sensing receptor in familial benign hypercalcaemia associated with partial lipoatrophy and insulin resistant diabetes
2000
The fasting hyperglycaemia study: I. Subject identification and recruitment for a non—insulin-dependent diabetes prevention trial
1997
Increased Ability of LDL from Normolipidemic Type 2 Diabetic Women to Generate Peroxides
1999
Comparison of blood glucose stability and HbA1C between implantable insulin pumps using U400 HOE 21PH insulin and external pumps using lispro in type 1 diabetic patients: a pilot study.
2002
Instant Power Spectrum Analysis of Heart Rate Variability During Orthostatic Tilt Using a Time-/Frequency-Domain Method
1997
The Benefits of Metformin Therapy During Continuous Subcutaneous Insulin Infusion Treatment of Type 1 Diabetic Patients
2002
Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
1999
Blood glucose control on Sunday in IDDM patients: intensified conventional insulin therapy versus continuous subcutaneous insulin infusion
1998
Comparison of Metabolic Deterioration between Insulin Analog and Regular Insulin after a 5-Hour Interruption of a Continuous Subcutaneous Insulin Infusion in Type 1 Diabetic Patients1
1999
Improvement of HbA1c and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps
1998